Publications by authors named "M Behe"

Claim this Profile
T
The "Two-Step Boost" for [Lu]Lu-PP-F11N Therapy: Optimization of Tumor Uptake by Premedication.
Christof Rottenburger, Martin T Freitag, M Aymen Omrane, Michael Hentschel, Martin Behe

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of radiolabeled bombesin analogs [Lu]Lu-AMBA and [Lu]Lu-RM2 for targeting GRPR in glioblastoma model.
Michal Grzmil, Muriel Aline Spahn, Philipp Berger, Roger Schibli, Martin Béhé

Nucl Med Biol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with Lu in Preclinical Models of Ovarian Cancer.
Tihomir Zh Todorov, Ricardo Coelho, Sharon Dellea, Francis Jacob, Viola Heinzelmann-Schwarz

J Nucl Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tb Radioimmunotherapy as a Treatment for CD30-Positive Lymphomas.
Elisa Rioja-Blanco, Yara Banz, Christoph Schlapbach, Urban Novak, Tanja Chiorazzo, Martin Behe

J Nucl Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphoproteomics Reveals L1CAM-Associated Signaling Networks in High-Grade Serous Ovarian Carcinoma: Implications for Radioresistance and Tumorigenesis.
Tihomir Zh Todorov, Ricardo Coelho, Francis Jacob, Viola Heinzelmann-Schwarz, Roger Schibli

Int J Mol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis